z-logo
open-access-imgOpen Access
The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
Author(s) -
Shahram Taheri,
Nooshin Keyvandarian,
Firouze‬h Moeinzadeh,
Mojgan Mortazavi,
Afsoon Emami Naini
Publication year - 2014
Publication title -
advanced biomedical research
Language(s) - English
Resource type - Journals
ISSN - 2277-9175
DOI - 10.4103/2277-9175.135160
Subject(s) - oxidative stress , medicine , continuous ambulatory peritoneal dialysis , lipid peroxidation , fish oil , lipid profile , endocrinology , fatty acid , ceruloplasmin , peritoneal dialysis , gastroenterology , biochemistry , chemistry , biology , cholesterol , fishery , fish <actinopterygii>
Background: End stage renal disease (ESRD) is a condition that inflammation and oxidative stress plays an important role in damaging to tissues, especially, in the vascular system. The effect of omega-3 fatty acids is well-documented in some inflammatory diseases via eicosapentanoic acid and docosahexanoic acid components of fish oil. The aim of this study was to investigate the effects of dietary omega-3 fatty acid supplementation on levels of lipid peroxidation and oxidative sttress in ESRD patients. Materials and Methods: This randomized controlled double-blind clinical trial consisted of 90 patients on chronic ambulatory peritoneal dialysis (CAPD). One group was treated orally with 3000 mg omega-3, per day for 8 weeks (n = 45) and the other matched group by placebo (n = 45). Serum levels of lipids, iron, ferritin, Protrombin Time, Partial thromboplastin time, superoxide dismutase (SOD), and reduced glutathione (GH) were measured at the beginning and at 8 weeks. Results: Our results showed that SOD and reduced GH were not significantly changed in omega-3 group where lipid profile showed no significant changes too. Erythropoietin requirements also had no significant differences.Conclusion: Incorporation of omega-3 fatty acids to CAPD patients had no beneficial effects on oxidative stress but should evaluate more

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here